Anti-TGF beta Receptor II (phospho S225) antibody [EPR12198]
- RabMAb
- Recombinant
- What is this?
5
(2 Reviews)
|
(7 Publications)
Rabbit Recombinant Monoclonal TGF beta Receptor II phospho S225 antibody. Suitable for WB and reacts with Human samples. Cited in 7 publications.
View Alternative Names
TGF-beta receptor type-2, TGFR-2, TGF-beta type II receptor, Transforming growth factor-beta receptor type II, TGF-beta receptor type II, TbetaR-II, TGFBR2
- WB
Supplier Data
Western blot - Anti-TGF beta Receptor II (phospho S225) antibody [EPR12198] (AB183037)
All lanes:
Western blot - Anti-TGF beta Receptor II (phospho S225) antibody [EPR12198] (ab183037) at 1/10000 dilution
Lane 1:
Lysate from HepG2 cells treated with TGF-β at 10 µg
Lane 2:
Lysate from HepG2 cells treated with TGF-β then treated with alkaline phosphatase at 10 µg
Lane 3:
Lysate from HepG2 cells at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated antibody at 1/1000 dilution
Predicted band size: 65 kDa
Observed band size: 70-80 kDa
false
Related conjugates and formulations (1)
-
Anti-TGF beta Receptor II (phospho S225) antibody [EPR12198] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (7)
Recent publications for all applications. Explore the full list and refine your search
Stem cell research & therapy 16:201 PubMed40264229
2025
Applications
Unspecified application
Species
Unspecified reactive species
iScience 28:111756 PubMed39925433
2025
Applications
Unspecified application
Species
Unspecified reactive species
Oncogene 42:3633-3647 PubMed37864034
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular physiology 237:1780-1789 PubMed34806177
2021
Applications
Unspecified application
Species
Unspecified reactive species
OncoTargets and therapy 14:1487-1499 PubMed33679133
2021
Applications
Unspecified application
Species
Unspecified reactive species
Pathobiology : journal of immunopathology, molecul 87:100-113 PubMed31896114
2020
Applications
Unspecified application
Species
Unspecified reactive species
Oncogene 38:4637-4654 PubMed30742067
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com